Nanomedicine: Tiny particles and machines give huge gains

Annals of Biomedical Engineering

Volumn 42, Issue 2, 2014, Pages 243-259

  Tong, Sheng ^a   Fine, Eli J ^a   Lin, Yanni ^a   Cradick, Thomas J ^a   Bao, Gang ^a  

^a Emory University   (United States)

Author keywords

Engineered nucleases; Genome editing; Molecular imaging probes; Multifunctional nanoparticle; Nanomedicine; Nanoparticles

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; GENES; MOLECULAR IMAGING; NANOPARTICLES; NANOTECHNOLOGY; NUCLEIC ACIDS; PROBES;

BIOLOGICAL PROCESS; BIOMOLECULAR ENGINEERING; CLINICAL APPLICATION; ENGINEERED NUCLEASES; MEDICAL DIAGNOSTICS; MOLECULAR MACHINES; MULTI-FUNCTIONAL NANOPARTICLES; NANOSCALE STRUCTURE;

MEDICAL NANOTECHNOLOGY;

CONTRAST MEDIUM; GOLD NANOPARTICLE; IRON OXIDE; MAGNETIC NANOPARTICLE; NANOCARRIER; NANOPARTICLE; NUCLEASE; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

CONFERENCE PAPER; ENZYME ENGINEERING; GENOME ANALYSIS; HYPERTHERMIA; MOLECULAR IMAGING; NANOMEDICINE; NANOPROBE; PARTICLE SIZE; PH; PRIORITY JOURNAL; THERAPY;

BIOENGINEERING; HUMANS; MOLECULAR IMAGING; NANOMEDICINE; NANOPARTICLES;

EID: 84899446339     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-013-0952-x     Document Type: Conference Paper

References (176)

1. Alexiou, C., et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60:6641-6648, 2000.
2. Alivisatos, P. The use of nanocrystals in biological detection. Nat. Biotechnol. 22:47-52, 2004.
3. Alivisatos, A. P., W. Gu, and C. Larabell. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 7:55-76, 2005.
4. Bao, G., S. Mitragotri, and S. Tong. Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. 15:253-282, 2013.
5. Bertolini, L. R., et al. Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the nonhomologous end-joining pathway. J. Biotechnol. 128:246-257, 2007.
6. Bitinaite, J., D. A. Wah, A. K. Aggarwal, and I. Schildkraut. FokI dimerization is required for DNA cleavage. Proc. Natl. Acad. Sci. USA 95:10570-10575, 1998.
7. Bjornerud, A., et al. Use of intravascular contrast agents in MRI. Acad. Radiol. 5(Suppl 1):S223-S225, 1998.
8. Boch, J., et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326:1509-1512, 2009.
9. Bolotin, A., B. Quinquis, A. Sorokin, and S. D. Ehrlich. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151:2551-2561, 2005.
10. Bonasio, R., et al. Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots. Proc. Natl. Acad. Sci. USA 104:14753-14758, 2007.
11. Boyer, D., P. Tamarat, A. Maali, B. Lounis, and M. Orrit. Photothermal imaging of nanometer-sized metal particles among scatterers. Science 297:1160-1163, 2002.
12. Brooks, R. A., F. Moiny, and P. Gillis. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn. Reson. Med. 45:1014-1020, 2001.
13. Bruchez, M., M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos. Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013-2016, 1998.
14. Brunetti, V., et al. InP/ZnS as a safer alternative to CdSe/ZnS core/shell quantum dots: in vitro and in vivo toxicity assessment. Nanoscale 5:307-317, 2013.
15. Busa, W. B., and R. Nuccitelli. Metabolic regulation via intracellular pH. Am. J. Physiol. 246:R409-R438, 1984.
16. Caldorera-Moore, M., and N. A. Peppas. Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems. Adv. Drug Deliv. Rev. 61:1391-1401, 2009.
17. Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9:653-660, 2003.
18. Champion, J. A., Y. K. Katare, and S. Mitragotri. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Controlled Release Off. J. Controlled Release Soc. 121:3-9, 2007.
19. Chan, W. C., and S. Nie. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281:2016-2018, 1998.
20. Chan, W. C. W., T. L. Prendergast, M. Jain, and S. Nie. One-step conjugation of biomolecules to luminescent nanocrystals. Proc. SPIE 3924:2-9, 2000.
21. Chang, E., et al. Protease-activated quantum dot probes. Biochem. Biophys. Res. Commun. 334:1317-1321, 2005.
22. Chattopadhyay, P. K., et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 12:972-977, 2006.
23. Cheng, Z., A. Al Zaki, J. Z. Hui, V. R. Muzykantov, and A. Tsourkas. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903-910, 2012.
24. Chilkoti, A., M. R. Dreher, D. E. Meyer, and D. Raucher. Targeted drug delivery by thermally responsive polymers. Adv. Drug Deliv. Rev. 54:613-630, 2002.
25. Cho, M. H., et al. A magnetic switch for the control of cell death signalling in in vitro and in vivo systems. Nat. Mater. 11:1038-1043, 2012.
26. Choi, J. S., et al. Self-confirming "AND" logic nanoparticles for fault-free MRI. J. Am. Chem. Soc. 132:11015-11017, 2010.
27. Christian, M. L., et al. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues. Plos One 7:e45383, 2012.
28. Clapp, A. R., et al. Quantum dot-based multiplexed fluorescence resonance energy transfer. J. Am. Chem. Soc. 127:18212-18221, 2005.
29. Clement, O., N. Siauve, C. A. Cuenod, and G. Frija. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Top. Magn. Reson. Imaging TMRI 9:167-182, 1998.
30. Cong, L., R. Zhou, Y. C. Kuo, M. Cunniff, and F. Zhang. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat. Commun. 3:968, 2012.
31. Cong, L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823, 2013.
32. Cornu, T. I., et al. DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol. Ther. J. Am. Soc. Gene Ther. 16:352-358, 2008.
33. Cradick, T. J., G. Ambrosini, C. Iseli, P. Bucher, and A. P. McCaffrey. ZFN-Site searches genomes for zinc finger nuclease target sites and off-target sites. BMC Bioinform. 12:152, 2011.
34. Cradick, T. J., E. J. Fine, C. J. Antico, and G. Bao. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41:9584-9592, 2013.
35. Cristea, S., et al. In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol. Bioeng. 110:871-880, 2013.
36. Dam, D. H., K. S. Culver, P. N. Sisco, and T. W. Odom. Shining light on nuclear-targeted therapy using gold nanostar constructs. Ther. Deliv. 3:1263-1267, 2012.
37. Dames, P., et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat. Nanotechnol. 2:495-499, 2007.
38. Dennis, A. M., and G. Bao. Quantum dot-fluorescent protein pairs as novel fluorescence resonance energy transfer probes. Nano Lett. 8:1439-1445, 2008.
39. Dennis, A. M., W. J. Rhee, D. Sotto, S. N. Dublin, and G. Bao. Quantum dot-fluorescent protein FRET probes for sensing intracellular pH. ACS Nano 6:2917-2924, 2012.
40. Dilnawaz, F., A. Singh, C. Mohanty, and S. K. Sahoo. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31:3694-3706, 2010.
41. Doshi, N., and S. Mitragotri. Designer biomaterials for nanomedicine. Adv. Funct. Mater. 19:3843-3854, 2009.
42. Doyon, Y., et al. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat. Methods 8:74-79, 2010.
43. Dreier, B., D. J. Segal, and C. F. Barbas, 3rd. Insights into the molecular recognition of the 5'-GNN-3' family of DNA sequences by zinc finger domains. J. Mol. Biol. 303:489-502, 2000.
44. Dubertret, B., et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298:1759-1762, 2002.
45. Engvall, E., and P. Perlmann. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin-G. Immunochemistry 8:871-874, 1971.
46. Euliss, L. E., J. A. Du Pont, S. Gratton, and J. De Simone. Imparting size, shape, and composition controlof materials for nanomedicine. Chem. Soc. Rev. 35:1095-1104, 2006.
47. Fortin, J. P., et al. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129:2628-2635, 2007.
48. Fu, Y., et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31:822-826, 2013.
49. Gannon, C. J., C. R. Patra, R. Bhattacharya, P. Mukherjee, and S. A. Curley. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J. Nanobiotechnol. 6:2, 2008.
50. Gao, X., Y. Cui, R. M. Levenson, L. W. Chung, and S. Nie. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22:969-976, 2004.
51. Garneau, J. E., et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67-71, 2010.
52. Garon, E. B., et al. Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk. Res. 31:643-651, 2007.
53. Gillis, P., and S. H. Koenig. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn. Reson. Med. 5:323-345, 1987.
54. Gillis, P., F. Moiny, and R. A. Brooks. On T (2)-shortening by strongly magnetized spheres: a partial refocusing model. Magn. Reson. Med. 47:257-263, 2002.
55. Gobin, A. M., et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 7:1929-1934, 2007.
56. Goldman, E. R., et al. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal. Chem. 74:841-847, 2002.
57. Guthi, J. S., et al. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol. Pharm. 7:32-40, 2010.
58. Halas, N. J. Playing with plasmons. Tuning the optical resonant properties of metallic nanoshells. Mrs. Bull. 30:362-367, 2005.
59. Hale, C. R., et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139:945-956, 2009.
60. Hama, Y., Y. Koyama, Y. Urano, P. L. Choyke, and H. Kobayashi. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res. Treat 103:23-28, 2007.
61. Hanna, J., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923, 2007.
62. Herrmann, F., et al. p53 gene repair with zinc finger nucleases optimised by yeast 1-hybrid and validated by Solexa Sequencing. Plos One 6:e20913, 2011.
63. Hirsch, L. R., et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100:13549-13554, 2003.
64. Hong, G., et al. In vivo fluorescence imaging with Ag2S quantum dots in the second near-infrared region. Angew. Chem. Int. Ed. Engl. 51:9818-9821, 2012.
65. Hook, A. L., et al. High throughput methods applied in biomaterial development and discovery. Biomaterials 31:187-198, 2010.
66. Horvath, P., and R. Barrangou. CRISPR/Cas, the immune system of bacteria and archaea. Science 327:167-170, 2010.
67. Howarth, M., K. Takao, Y. Hayashi, and A. Y. Ting. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc. Natl. Acad. Sci. USA 102:7583-7588, 2005.
68. Hsu, P. D., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31:827-832, 2013.
69. Huang, X. H., I. H. El-Sayed, W. Qian, and M. A. El-Sayed. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128:2115-2120, 2006.
70. Jain, P. K., X. H. Huang, I. H. El-Sayed, and M. A. El-Sayed. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc. Chem. Res. 41:1578-1586, 2008.
71. Jain, P. K., K. S. Lee, I. H. El-Sayed, and M. A. El-Sayed. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B 110:7238-7248, 2006.
72. Jain, T. K., et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29:4012-4021, 2008.
73. Jaiswal, J. K., H. Mattoussi, J. M. Mauro, and S. M. Simon. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21:47-51, 2003.
74. Jamieson, A. C., S. H. Kim, and J. A. Wells. In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry 33:5689-5695, 1994.
75. Jana, N. R., Y. F. Chen, and X. G. Peng. Size- and shapecontrolled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach. Chem. Mater. 16:3931-3935, 2004.
76. Jang, J. T., et al. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew. Chem. Int. Ed. 48:1234-1238, 2009.
77. Joung, J. K., E. I. Ramm, and C. O. Pabo. A bacterial two-hybrid selection system for studying protein-DNA and protein-protein interactions. Proc. Natl. Acad. Sci. USA 97:7382-7387, 2000.
78. Jun, Y. W., J. W. Seo, and A. Cheon. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res. 41:179-189, 2008.
79. Jun, Y. W., et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 127:5732-5733, 2005.
80. Kim, Y. G., and S. Chandrasegaran. Chimeric restriction endonuclease. Proc. Natl. Acad. Sci. USA 91:883-887, 1994.
81. Kim, J. S., and C. O. Pabo. Getting a handhold on DNA: design of poly-zinc finger proteins with femtomolar dissociation constants. Proc. Natl. Acad. Sci. USA 95:2812-2817, 1998.
82. Kim, B. Y., J. T. Rutka, and W. C. Chan. Nanomedicine. N. Engl. J. Med. 363:2434-2443, 2010.
83. Kim, J., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. Engl. 47:8438-8441, 2008.
84. Koenig, S. H., and K. E. Kellar. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn. Reson. Med. 34:227-233, 1995.
85. Krishnan, K. M., et al. Nanomagnetism and spin electronics: materials, microstructure and novel properties. J. Mater. Sci. 41:793-815, 2006.
86. Landazuri, N., et al. Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. Small, 2013. doi: 10.1002/smll.201300570.
87. Lee, C. M., R. Flynn, J. A. Hollywood, M. F. Scallan, and P. T. Harrison. Correction of the ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair. Biores. Open Access 1:99-108, 2012.
88. Lee, J. H., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13:95-99, 2007.
89. Lee, J. H., et al. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed. Engl. 48:4174-4179, 2009.
90. Lee, J. H., et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 6:418-422, 2011.
91. Lewin, M., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:410-414, 2000.
92. Li, W., and F. C. Szoka, Jr. Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24:438-449, 2007.
93. Liong, M., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2:889-896, 2008.
94. Mali, P., et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31:833-838, 2013.
95. Mallidi, S., T. Larson, J. Aaron, K. Sokolov, and S. Emelianov. Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt. Express 15:6583-6588, 2007.
96. Marraffini, L. A., and E. J. Sontheimer. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat. Rev. Genet. 11:181-190, 2010.
97. Medarova, Z., W. Pham, C. Farrar, V. Petkova, and A. Moore. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13:372-377, 2007.
98. Medintz, I. L., H. T. Uyeda, E. R. Goldman, and H. Mattoussi. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4:435-446, 2005.
99. Medintz, I. L., et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantumdot-peptide conjugates. Nat. Mater. 5:581-589, 2006.
100. Miller, J. C., et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25:778-785, 2007.
101. Montet, X., K. Montet-Abou, F. Reynolds, R. Weissleder, and L. Josephson. Nanoparticle imaging of integrins on tumor cells. Neoplasia 8:214-222, 2006.
102. Moscou, M. J., and A. J. Bogdanove. A simple cipher governs DNA recognition by TAL effectors. Science 326:1501, 2009.
103. Mussolino, C., et al. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res. 39:9283-9293, 2011.
104. Nahrendorf, M., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504-1511, 2006.
105. Namiki, Y., et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat. Nanotechnol. 4:598-606, 2009.
106. Nie, S. M., X. Yun, J. K. Gloria, and J. W. Simmons. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 9:257-288, 2007.
107. Nitin, N., L. E. La Conte, O. Zurkiya, X. Hu, and G. Bao. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorg. Chem. 9:706-712, 2004.
108. Nobuto, H., et al. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int. J. Cancer 109:627-635, 2004.
109. Osborn, M. J., et al. TALEN-based gene correction for epidermolysis Bullosa. Mol. Ther. 21:1151-1159, 2013.
110. Park, J. H., G. Von Maltzahn, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem. Int. Ed. 47:7284-7288, 2008.
111. Park, J. H., et al. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv. Mater. 20:1630-1635, 2008.
112. Pellegrino, T., et al. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: a general route to water soluble nanocrystals. Nano Lett. 4:703-707, 2004.
113. Perez, J. M., L. Josephson, T. O'Loughlin, D. Hogemann, and R. Weissleder. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 20:816-820, 2002.
114. Perez, E. E., J. Wang, J. C. Miller, Y. Jouvenot, K. A. Kim, O. Liu, N. Wang, G. Lee, V. V. Bartsevich, Y. L. Lee, D. Y. Guschin, I. Rupniewski, A. J. Waite, C. Carpenito, R. G. Carroll, J. S. Orange, F. D. Urnov, E. J. Rebar, D. Ando, P. D. Gregory, J. L. Riley, M. C. Holmes, and C. H. June. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 26:808-816, 2008.
115. Platt, O. S., D. J. Brambilla, W. F. Rosse, P. F. Milner, O. Castro, M. H. Steinberg, and P. P. Klug. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330:1639-1644, 1994.
116. Popovtzer, R., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 8:4593-4596, 2008.
117. Porteus, M. H., and D. Baltimore. Chimeric nucleases stimulate gene targeting in human cells. Science 300:763, 2003.
118. Pridgen, E. M., R. Langer, and O. C. Farokhzad. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond) 2:669-680, 2007.
119. Prodan, E., C. Radloff, N. J. Halas, and P. Nordlander. A hybridization model for the plasmon response of complex nanostructures. Science 302:419-422, 2003.
120. Qian, X., et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26:83-90, 2008.
121. Ramirez, C. L., et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res. 40:5560-5568, 2012.
122. Rebar, E. J., and C. O. Pabo. Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science 263:671-673, 1994.
123. Reyon, D., et al. FLASH assembly of TALENs for highthroughput genome editing. Nat. Biotechnol. 30:460-465, 2012.
124. Rodriguez-Oliveros, R., and J. A. Sanchez-Gil. Gold nanostars as thermoplasmonic nanoparticles for optical heating. Opt. Express 20:621-626, 2012.
125. Rosensweig, R. E. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252:370-374, 2002.
126. Rouet, P., F. Smih, and M. Jasin. Expression of a sitespecific endonuclease stimulates homologous recombination in mammalian cells. Proc. Natl. Acad. Sci. USA 91:6064-6068, 1994.
127. Sandell, E. B., and H. Onishi. Photometric Determination of Traces of Metals (4th ed.). New York: Wiley, 1978.
128. Sander, J. D., et al. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat. Biotechnol. 29:697-698, 2011.
129. Santra, S., C. Kaittanis, J. Grimm, and J. M. Perez. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 5:1862-1868, 2009.
130. Schmid-Burgk, J. L., T. Schmidt, V. Kaiser, K. Honing, and V. Hornung. A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nat. Biotechnol. 31:76-81, 2013.
131. Schroeder, A., et al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12:39-50, 2012.
132. Segal, D. J., and J. F. Meckler. Genome engineering at the dawn of the golden age. Annu. Rev. Genomics Hum. Genet. 14:135-158, 2013.
133. Shin, J. M., et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed. 48:321-324, 2009.
134. Skrabalak, S. E., L. Au, X. D. Li, and Y. N. Xia. Facile synthesis of Ag nanocubes and Au nanocages. Nat. Protoc. 2:2182-2190, 2007.
135. Smith, J., et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28:3361-3369, 2000.
136. Stanley, S. A., et al. Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 336:604-608, 2012.
137. Streubel, J., C. Blucher, A. Landgraf, and J. Boch. TAL effector RVD specificities and efficiencies. Nat. Biotechnol. 30:593-595, 2012.
138. Sun, N., J. Liang, Z. Abil, and H. Zhao. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol. Biosyst. 8:1255-1263, 2012.
139. 4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc. 126:273-279, 2004.
140. Szczepek, M., et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat. Biotechnol. 25:786-793, 2007.
141. Tang, T., et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using highresolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke J. Cereb. Circ. 37:2266-2270, 2006.
142. Thu, M. S., et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 18:463-467, 2012.
143. Tong, S., S. Hou, B. Ren, Z. Zheng, and G. Bao. Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange. Nano Lett. 11:3720-3726, 2011.
144. Tong, S., S. J. Hou, Z. L. Zheng, J. Zhou, and G. Bao. Coating optimization of superparamagnetic iron oxide nanoparticles for high T-2 relaxivity. Nano Lett. 10:4607-4613, 2010.
145. Tong, S., B. Ren, Z. Zheng, and G. Bao. Tiny grains give huge gains: nanocrystal-based signal amplification for immunosorbent assays. ACS Nano 7:5142-5150, 2013.
146. Torchilin, V. P., and V. S. Trubetskoy. Which polymers can make nanoparticulate drug carriers long-circulating. Adv. Drug Deliv. Rev. 16:141-155, 1995.
147. Tromberg, B. J., et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2:26-40, 2000.
148. Tromsdorf, U. I., et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett. 7:2422-2427, 2007.
149. Urnov, F. D., et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646-651, 2005.
150. Vanweeme, B. K., and A. H. W. Schuurs. Immunoassay using antigen-enzyme conjugates. Febs Lett. 15:232-236, 1971.
151. Von Maltzahn, G., et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69:3892-3900, 2009.
152. Voura, E. B., J. K. Jaiswal, H. Mattoussi, and S. M. Simon. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emissionscanning microscopy. Nat. Med. 10:993-998, 2004.
153. Wagner, V., A. Dullaart, A. K. Bock, and A. Zweck. The emerging nanomedicine landscape. Nat. Biotechnol. 24:1211-1217, 2006.
154. Wang, Y. X., S. M. Hussain, and G. P. Krestin. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11:2319-2331, 2001.
155. Wang, Y. A., J. J. Li, H. Chen, and X. Peng. Stabilization of inorganic nanocrystals by organic dendrons. J. Am. Chem. Soc. 124:2293-2298, 2002.
156. Wang, Y., et al. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain. Nano Lett. 4:1689-1692, 2004.
157. Weber, E., R. Gruetzner, S. Werner, C. Engler, and S. Marillonnet. Assembly of designer TAL effectors by golden gate cloning. Plos One 6:e19722, 2011.
158. Weissleder, R., A. Bogdanov, E. A. Neuwelt, and M. Papisov. Long-circulating iron-oxides for MR imaging. Adv. Drug Deliv. Rev. 16:321-334, 1995.
159. Weissleder, R., et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152:167-173, 1989.
160. Wiedenheft, B., S. H. Sternberg, and J. A. Doudna. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482:331-338, 2012.
161. Winter, P. M., et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrintargeted nanoparticles. Circulation 108:2270-2274, 2003.
162. Wood, A. J., T. W. Lo, B. Zeitler, C. S. Pickle, E. J. Ralston, A. H. Lee, R. Amora, J. C. Miller, E. Leung, X. Meng, L. Zhang, E. J. Rebar, P. D. Gregory, F. D. Urnov, and B. J. Meyer. Targeted genome editing across species using ZFNs and TALENs. Science 333:307, 2011.
163. Wu, X., et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21:41-46, 2003.
164. Xiao, A., et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res., 2013. doi:10.1093/nar/gkt464.
165. Xie, J., J. Huang, X. Li, S. Sun, and X. Chen. Iron oxide nanoparticle platform for biomedical applications. Curr. Med. Chem. 16:1278-1294, 2009.
166. 4/Au/Ag nanoparticles with tunable plasmonic properties. J. Am. Chem. Soc. 129:8698, 2007.
167. Xu, C. J., and S. H. Sun. Monodisperse magnetic nanoparticles for biomedical applications. Polym. Int. 56:821-826, 2007.
168. Xu, C., B. Xing, and J. Rao. A self-assembled quantum dot probe for detecting beta-lactamase activity. Biochem. Biophys. Res. Commun. 344:931-935, 2006.
169. Yang, X., S. E. Skrabalak, Z. Y. Li, Y. Xia, and L. V. Wang. Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. Nano Lett. 7:3798-3802, 2007.
170. Yang, X., E. W. Stein, S. Ashkenazi, and L. V. Wang. Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:360-368, 2009.
171. Yao, H., Y. Zhang, F. Xiao, Z. Xia, and J. Rao. Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases. Angew. Chem. Int. Ed. 46:4346-4349, 2007.
172. Yavuz, M. S., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat. Mater. 8:935-939, 2009.
173. Yu, W. W., E. Chang, C. M. Sayes, R. Drezek, and V. L. Colvin. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology 17:4483-4487, 2006.
174. Yu, W. W., J. C. Falkner, C. T. Yavuz, and V. L. Colvin. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem. Commun. 2306-2307, 2004.
175. Zharov, V. P., E. N. Galitovskaya, C. Johnson, and T. Kelly. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg. Med. 37:219-226, 2005.
176. Zhu, M. T., B. Wang, Y. Wang, L. Yuan, H. J. Wang, M. Wang, H. Ouyang, Z. F. Chai, W. Y. Feng, and Y. L. Zhao. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. Toxicol. Lett. 203:162-171, 2011.